Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noam Barda

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Infection Control and Hospital Epidemiology|July 31, 2025
Impact of asymptomatic <i>Clostridioides difficile</i> carriage screening on antibiotic stewardship among hospitalized patientsMayan Gilboa, Eyal Meltzer, Noam Barda, et al.
JAMA Network Open|August 8, 2025
Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile InfectionMayan Gilboa, Gili Regev-Yochay, Eyal Meltzer, et al.
The New England Journal of Medicine|October 6, 2021
Myocarditis after Covid-19 Vaccination in a Large Health Care OrganizationGuy Witberg, Noam Barda, Sara Hoss, et al.
Science (New York, N.Y.)|January 27, 2022
Indirect protection of children from SARS-CoV-2 infection through parental vaccinationSamah Hayek, Galit Shaham, Yatir Ben-Shlomo, et al.
The New England Journal of Medicine|February 24, 2021
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingNoa Dagan, Noam Barda, Eldad Kepten, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 13, 2024
SARS-CoV-2 Omicron XBB.1 variant outbreak in a defined cohort: an epidemiological investigation incorporating longitudinal assessment of humoral responseIli Margalit, Yael Weiss-Ottolenghi, Einat Panet, et al.
Vaccine|September 10, 2024
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workersMichal Canetti, Noam Barda, Yaniv Lustig, et al.
Nature Communications|August 2, 2022
Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomesSamah Hayek, Yatir Ben-Shlomo, Noa Dagan, et al.
The New England Journal of Medicine|August 25, 2021
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide SettingNoam Barda, Noa Dagan, Yatir Ben-Shlomo, et al.
Vaccine|May 28, 2024
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccinesYaniv Lustig, Noam Barda, Yael Weiss-Ottolenghi, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Infection Control and Hospital Epidemiology|July 31, 2025
Impact of asymptomatic <i>Clostridioides difficile</i> carriage screening on antibiotic stewardship among hospitalized patientsMayan Gilboa, Eyal Meltzer, Noam Barda, et al.
JAMA Network Open|August 8, 2025
Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile InfectionMayan Gilboa, Gili Regev-Yochay, Eyal Meltzer, et al.
The New England Journal of Medicine|October 6, 2021
Myocarditis after Covid-19 Vaccination in a Large Health Care OrganizationGuy Witberg, Noam Barda, Sara Hoss, et al.
Science (New York, N.Y.)|January 27, 2022
Indirect protection of children from SARS-CoV-2 infection through parental vaccinationSamah Hayek, Galit Shaham, Yatir Ben-Shlomo, et al.
The New England Journal of Medicine|February 24, 2021
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingNoa Dagan, Noam Barda, Eldad Kepten, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 13, 2024
SARS-CoV-2 Omicron XBB.1 variant outbreak in a defined cohort: an epidemiological investigation incorporating longitudinal assessment of humoral responseIli Margalit, Yael Weiss-Ottolenghi, Einat Panet, et al.
Vaccine|September 10, 2024
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workersMichal Canetti, Noam Barda, Yaniv Lustig, et al.
Nature Communications|August 2, 2022
Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomesSamah Hayek, Yatir Ben-Shlomo, Noa Dagan, et al.
The New England Journal of Medicine|August 25, 2021
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide SettingNoam Barda, Noa Dagan, Yatir Ben-Shlomo, et al.
Vaccine|May 28, 2024
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccinesYaniv Lustig, Noam Barda, Yael Weiss-Ottolenghi, et al.
Pageof 6